amrinone has been researched along with Blood Pressure, Low in 7 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of amrinone-induced thrombocytopenia has been reported to be 2." | 7.68 | Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone. ( Burnette, PK; Manny, RP; Mattingly, PM; Weston, MW, 1990) |
| "Clinical trials of intravenous amrinone were performed in 462 patients severely ill with congestive heart failure." | 5.05 | Clinical safety of intravenous amrinone--a review. ( Treadway, G, 1985) |
| "The incidence of amrinone-induced thrombocytopenia has been reported to be 2." | 3.68 | Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone. ( Burnette, PK; Manny, RP; Mattingly, PM; Weston, MW, 1990) |
| "We gave intravenous amrinone to 40 patients in heart failure, and oral amrinone to 18 patients." | 3.66 | Side effects of amrinone therapy. ( Webb-Peploe, MM; Wilsmhurst, PT, 1983) |
| " Vasodilator therapy generally fails to reduce pulmonary vascular resistance selectively during long-term administration and frequently leads to systemic hypotension, exacerbation of the pulmonary hypertensive state, worsening of right ventricular failure, and systemic arterial desaturation." | 2.37 | Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards. ( Packer, M, 1985) |
| "Amrinone and glucagon have been used separately and in combination with other agents in the treatment of calcium channel blocker overdose." | 1.29 | Use of amrinone and glucagon in a case of calcium channel blocker overdose. ( Otten, EJ; Spadafora, MP; Wolf, LR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilsmhurst, PT | 1 |
| Webb-Peploe, MM | 1 |
| Love, JN | 1 |
| Leasure, JA | 1 |
| Mundt, DJ | 1 |
| Wolf, LR | 1 |
| Spadafora, MP | 1 |
| Otten, EJ | 1 |
| Tuncok, Y | 1 |
| Apaydin, S | 1 |
| Kalkan, S | 1 |
| Ates, M | 1 |
| Guven, H | 1 |
| Mattingly, PM | 1 |
| Burnette, PK | 1 |
| Weston, MW | 1 |
| Manny, RP | 1 |
| Packer, M | 1 |
| Treadway, G | 1 |
1 review available for amrinone and Blood Pressure, Low
| Article | Year |
|---|---|
Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Blood Pressure; Ca | 1985 |
1 trial available for amrinone and Blood Pressure, Low
| Article | Year |
|---|---|
Clinical safety of intravenous amrinone--a review.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Drug I | 1985 |
5 other studies available for amrinone and Blood Pressure, Low
| Article | Year |
|---|---|
Side effects of amrinone therapy.
Topics: Administration, Oral; Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Female; Heart Failu | 1983 |
A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine model.
Topics: Amrinone; Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Depression, Chemical; Dogs; | 1993 |
Use of amrinone and glucagon in a case of calcium channel blocker overdose.
Topics: Adult; Amrinone; Drug Overdose; Drug Therapy, Combination; Female; Glucagon; Humans; Hypotension; Ve | 1993 |
The effects of amrinone and glucagon on verapamil-induced cardiovascular toxicity in anaesthetized rats.
Topics: Amrinone; Animals; Blood Pressure; Bradycardia; Calcium Channel Blockers; Cardiovascular Diseases; D | 1996 |
Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone.
Topics: Amrinone; Bone Marrow; Dopamine; Heart Failure; Humans; Hypotension; Infusions, Intravenous; Male; M | 1990 |